ARTV
Artiva Biotherapeutics, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Artiva Biotherapeutics (ARTV) Stock: Buy, Sell, or Hold?
$4.01
+0.05 (+1.26%)
▲
5d:
-3.37%
30d:
-33.83%
90d:
-65.84%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (90%)
Quality Score
49/100
Position
OVERSOLD
30-Day Fair Range
$4.18 – $6.59
Position: OVERSOLD
Forward P/E & Valuation
-2.0x
Next 12M consensus est.
Wall Street Target
$20.75
+417.5% upside
Options IV & Volume
MODERATE Vol
MODERATE volume confirmation
Support / Resistance
$3.91 / $4.28
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ARTV shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When ARTV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ARTV is currently trading at $4.01, which is considered oversold relative to its 30-day fair value range of $4.18 to $6.59.
Technical Outlook: Technically, ARTV is in a strong downtrend. The price is currently testing key support at $3.90. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ARTV scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $20.75 (+417.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ARTV is in a strong downtrend. The price is currently testing key support at $3.90. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ARTV scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $20.75 (+417.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.18 -
$6.59
Company Quality Score
49/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
89.5%
Trading Range & Key Levels
30-Day Trading Range
$4.18 -
$6.59
Current vs Trading Range
OVERSOLD
Support Level
$3.91
Resistance Level
$4.28
Current Trend
Strong Downtrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: Trading 417.5% below Wall St target ($20.75)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-2.02
Wall Street Target
$20.75
(+417.5%)
Revenue Growth (YoY)
-100.0%
Share ARTV Analysis
Share this live ARTV analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ARTV)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 1, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits message suggests that Artiva Biotherapeutics ($ARTV) could partner with Chemomab to conduct the Phase 3 PSC trial for a specific drug, which Chemomab has been trying to do since 2024. No recent news articles were available.
Key Retail Themes:
potential partnership
Phase 3 PSC trial
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:20 PM ET
Data refreshes hourly during market hours. Next update: 6:20 PM
Data refreshes hourly during market hours. Next update: 6:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARTV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 54 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 45 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 58 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 42 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 49 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ARTV Research Pages
